Lung Cancer in Malaysia.

[1]  P. Cheah,et al.  Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society. , 2019, Lung cancer.

[2]  A. Rhodes,et al.  Anaplastic lymphoma kinase (ALK) mutations in patients with adenocarcinoma of the lung , 2017, British journal of biomedical science.

[3]  S. How,et al.  Survival of lung cancer patients in a resource‐limited country , 2015, Asia-Pacific journal of clinical oncology.

[4]  C. Liam,et al.  Lung cancer staging now and in the future , 2015, Respirology.

[5]  S. How,et al.  Epidermal growth factor receptor mutations in non- small cell lung cancers in a multiethnic malaysian patient population. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[6]  B. Furlow.  Low-dose computed tomography lung cancer screening. , 2014, Radiologic technology.

[7]  A. Sachithanandan,et al.  Screening for lung cancer in Malaysia: are we there yet? , 2012, The Medical journal of Malaysia.

[8]  S. How,et al.  Defaulters among lung cancer patients in a suburban district in a developing country , 2012, Annals of thoracic medicine.

[9]  L. Loh,et al.  Survival in Patients with Non-Small Cell Lung Cancer Who Opted out of Cancer-Specific Therapy. , 2006, The Malaysian journal of medical sciences : MJMS.

[10]  L. Hooi,et al.  Survival of patients surgically treated for lung cancer. , 2003, The Medical journal of Malaysia.

[11]  C. Liam,et al.  Lung cancer in patients younger than 40 years in a multiracial Asian country , 2000, Respirology.